GSK Files New Suit Against Teva Over Generic Wellbutrin
GlaxoSmithKline LLC on Thursday filed a second lawsuit in Pennsylvania federal court against Teva Pharmaceuticals USA Inc. over a generic version of Wellbutrin XL, this time alleging Teva's false advertising that...To view the full article, register now.
Already a subscriber? Click here to view full article